Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

MultiPark

MultiPark (Multidisciplinary research focused on Parkinson´s disease) is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson's and Alzheimer's disease at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.

Microscope. Photo.

Calendar

Sep

16 September 2021 08:00 | Conference

“Non-motor Symptoms in Parkinson´s disease and Atypical Parkinsonism: Knowing the Unknown”

Oct

14 October 2021 16:30 | Lecture/talk

Frontiers in Neuroscience seminar: “From Protein Metabolism to Biomarkers and Prevention Trials”

Oct

26 October 2021 09:00 to 12:00 | Conference

SRA workshop series: Finding opportunities for solving real world problems

Nov

10 November 2021 09:00 to 12:00 | Conference

SRA workshop series: SDG 7 Affordable and clean energy: The goal is to ensure access to affordable, reliable, sustainable and modern energy for all by 2030

Nov

25 November 2021 09:00 to 12:00 | Conference

SRA workshop series: Social and environmental impacts across contexts - bringing in global perspectives

Audience listening to a talk.

Frontiers in Neuroscience Seminars

Blue neuron. Photo.

LU Neuroscience Portal

Sponsored by MultiPark

Yellow petals. Photo.

MultiPark events

News

An illustration showing a rat injected with alpha-synuclein. A zoomed in circle displays immune cells in the brain.

28 Jun 2021 | News

Does our immune response affect the risk of developing Parkinson’s disease?

T-cells, antibodies, and antigens. During the past year, we have learned a lot about our immune system through media. Most people agree that the immune system is crucial for our survival. But how does the immune system affect Parkinson’s disease; is it necessary to keep our brains healthy, or does i...

Photo of a dinner together with Angela Cenci Nilsson's research team.

8 Jun 2021 | News

Interview – Angela Cenci Nilsson about being the new coordinator for MultiPark

On the first of January, Professor Angela Cenci Nilsson took on as the new coordinator for MultiPark. Now she tells us about her visions for our network and about being a senior researcher in the environment.

A photo of boxes with samples in the freezer.

1 Jun 2021 | News

New biobank provides insights into Parkinson’s disease

Around 20 000 Swedes are currently suffering from Parkinson’s disease, yet there are still only treatments to alleviate symptoms. Through a new biobank, researchers gain access to the genetic profiles of 1000 Parkinson’s patients together with comprehensive information about their lifestyles and med...

27 May 2021 | News

PhD defence interview - Yiyi Yang

During her Ph.D. studies, Yiyi Yang has been investigating the role of microglia in the pathological development of Alzheimer’s disease. On the 3rd of June, it is time to defend her work supervised by Prof. Tomas Deierborg. Now, Yiyi tells us about her research in the Experimental Neuroinflammation ...

An illustration showing how a blood sample and cognitive tests can be used to calculate the risk of developing Alzheimer’s disease.

24 May 2021 | News

Simple diagnostic tool predicts individual risk of Alzheimer's

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer's disease in the future. The findings are published in Nature Medicine.

External links
The Swedish Parkinson Foundation
SWEBAGS - Swedish Basal Ganglia Society
Parkinsonförbundet (Swedish website)
Alzheimerfonden (Swedish website)